The U.S. Food and Drug Administration announced today that it has approved Creon (pancrelipase), a pancreatic enzyme replacement product designed to help patients with cystic fibrosis and others with exocrine pancreatic insufficiency (EPI) digest and absorb nutrients from foods
Read the original:
FDA Approves Pancreatic Enzyme Replacement Product for Marketing in United States
The recall is limited to the Triage Cardiac Panel, Catalog No. 97000HS, Lot No.
See the rest here:
Biosite Incorporated Issues Voluntary, Nationwide Recall for Cardiac Marker Test (May 5)
The U.S. Food and Drug Administration is warning consumers to immediately stop using Hydroxycut products by Iovate Health Sciences Inc., of Oakville, Ontario and distributed by Iovate Health Sciences USA Inc.
See the rest here:
FDA Warns Consumers to Stop Using Hydroxycut Products (May 1)